EICHORCondition: Major Depressive Disorder (MDD) · Sponsor: Vanda Pharmaceuticals
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of this study is to determine the efficacy and safety of milsaperidone compared to placebo as adjunctive therapy in patients with Major Depressive Disorder
This description comes directly from the study's public registry record.
Vanda Pharmaceuticals · 202-734-3400 · clinicaltrials@vandapharma.com
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Male or female patient 18 to 65 years of age, inclusive; * Meets DSM-5-TR criteria for MDD * Currently having an inadequate response to antidepressant therapy as confirmed by the Investigator using the Antidepressant Treatment Response Questionnaire (ATRQ) Exclusion Criteria: * Within the patients lifetime, has a confirmed DSM-5-TR psychiatric diagnosis other than MDD * Within 6 months of Screening, has a confirmed DSM-5-TR psychiatric diagnosis other than MDD * Within 12 months of Screening, has had any other psychiatric condition (other than MDD) that has been the main focus of treatment
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Vanda Investigational Site | Phoenix, Arizona, United States | Recruiting |
| Vanda Investigational Site | Little Rock, Arkansas, United States | Recruiting |
| Vanda Investigational Site | Garden Grove, California, United States | Recruiting |
| Vanda Investigational Site | Lemon Grove, California, United States | Recruiting |
| Vanda Investigational Site | Orange, California, United States | Recruiting |
| Vanda Investigational Site | San Jose, California, United States | Recruiting |
| Vanda Investigational Site | Walnut Creek, California, United States | Recruiting |
| Vanda Investigational Site | Colorado Springs, Colorado, United States | Recruiting |
| Vanda Investigational Site | Fort Myers, Florida, United States | Recruiting |
| Vanda Investigational Site | Miami, Florida, United States | Active Not Recruiting |
| Vanda Investigational Site | Miami, Florida, United States | Recruiting |
| Vanda Investigational Site | Tampa, Florida, United States | Active Not Recruiting |
+ 26 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06830044